Sebetralstat was first introduced by Kalvista Pharmaceuticals Ltd in its drug Ekterly on Jul 3, 2025.

Sebetralstat Patents

Given below is the list of patents protecting Sebetralstat, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)

• Argentina (AR)
• Australia (AU)
• Brazil (BR)
• Canada (CA)
• Chile (CL)
• China (CN)
• India (IN)
• Japan (JP)
• Mexico (MX)
• Paraguay (PY)
• Philippines (PH)
• Russia (RU)
• Singapore (SG)
• South Africa (ZA)
• Thailand (TH)
• United States (US)
• Uruguay (UY)
• Eurasian Patent Organization (EA)
• World Intellectual Property Organization (WO)
• Taiwan (TW)
• European Patent Office (EP)

Patent Category : All

• All
• Combination
• Compound
• Device
• Dosage Regimen
• Formulation
• Other Forms
• Polymorph
• Process
• Use Method

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Ekterly	US11234939		Jan 26, 2039	Kalvista
Ekterly	US11230537		Dec 25, 2037	Kalvista
Ekterly	US11739068		Jun 23, 2037	Kalvista
Ekterly	US10364238		Nov 26, 2035	Kalvista
Ekterly	US10611758		Nov 26, 2035	Kalvista
Ekterly	US11001578		Nov 26, 2035	Kalvista
Ekterly	US11084809		Nov 26, 2035	Kalvista
Ekterly	US11198691		Nov 26, 2035	Kalvista

Add above patents to watchlist

Sebetralstat's Family Patents

Unlock Global Patents

Sebetralstat Generic API Manufacturers

Given below is the list of companies who have filed for Sebetralstat generic, along with the locations of their manufacturing plants worldwide.